findmyKOL

Directory

KOLs working with Adaptive Biotechnologies

28 key opinion leaders with clinical trial sponsorships or reported industry payments from Adaptive Biotechnologies. Relationships are drawn from ClinicalTrials.gov sponsor records and CMS Open Payments, with every number cited to its source.

The 24 most cited

Paul Richardson, MD

Dana-Farber Cancer Institute

Active 2026
Enriched profilefindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileMyelomaHematology / OncologyNortheast · MA
2,062
publications
172
h-index
17
trials
View profile →

Gareth Morgan, MD

NYU Langone Health

Active 2026
Enriched profilefindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileMyelomaHematology / OncologyNortheast · NY
1,922
publications
126
h-index
4
trials
View profile →

Stephan Grupp, MD

Children's Hospital of Philadelphia

Active 2026
Enriched profilefindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLeukemiaHematology / OncologyNortheast · PA
804
publications
105
h-index
13
trials
View profile →

William Wierda, MD, PhD

The University of Texas MD Anderson Cancer Center

Active 2026
Enriched profileLeukemiaHematology / OncologySouth Central · TX
1,533
publications
122
h-index
19
trials
View profile →

Elias Jabbour, MD

The University of Texas MD Anderson Cancer Center

Active 2026
Enriched profilefindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLeukemiaHematology / OncologySouth Central · TX
2,365
publications
115
h-index
38
trials
View profile →

Robert Orlowski, MD

The University of Texas MD Anderson Cancer Center

Active 2026
Enriched profilefindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileMyelomaHematology / OncologySouth Central · TX
1,164
publications
102
h-index
10
trials
View profile →

Rafael Fonseca, MD

Mayo Clinic

Active 2026
Enriched profilefindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileMyelomaHematologyWest · AZ
894
publications
121
h-index
3
trials
View profile →

David Siegel, MD

John Theurer Cancer Center

Active 2026
Enriched profilefindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileMyelomaMedical OncologyNortheast · NJ
699
publications
83
h-index
9
trials
View profile →

Daniel Deangelo, MD

Dana-Farber Cancer Institute

Active 2026
Enriched profilefindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLeukemiaHematology / OncologyNortheast · MA
933
publications
93
h-index
10
trials
View profile →

Tapan Kadia, MD

The University of Texas MD Anderson Cancer Center

Active 2026
Enriched profileLeukemiaInternal MedicineSouth Central · TX
1,816
publications
91
h-index
30
trials
View profile →

Frederick Locke, MD

H. Lee Moffitt Cancer Center and Research Institute

Active 2026
Enriched profilefindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileMyelomaHematology / OncologySoutheast · FL
863
publications
62
h-index
8
trials
View profile →

Richard Maziarz, MD

Oregon Health & Science University

Active 2026
Enriched profilefindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLeukemiaHematology / OncologyWest · OR
720
publications
86
h-index
9
trials
View profile →

Parameswaran Hari, MD

Obsidian Therapeutics

Active 2025
Enriched profilefindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileMyelomaHematology / OncologyMidwest · WI
917
publications
79
h-index
6
trials
View profile →

Paul Barr, MD

University of Rochester Medical Center

Active 2026
Enriched profilefindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileHematologyHematologyNortheast · NY
837
publications
55
h-index
32
trials
View profile →

Andrzej Jakubowiak, MD, PhD

University of Chicago

Active 2026
Enriched profilefindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileMyelomaMedical OncologyMidwest · IL
477
publications
68
h-index
11
trials
View profile →

Michael Verneris, MD

University of Colorado School of Medicine

Active 2025
Enriched profilefindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileGenitourinaryHematology / OncologyWest · CO
497
publications
67
h-index
6
trials
View profile →

Ivan Borrello, MD

Tampa General Hospital Cancer Institute

Active 2025
Enriched profilefindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileMyelomaMedical OncologySoutheast · FL
282
publications
60
h-index
7
trials
View profile →

Matthew Davids, MD

Dana-Farber Cancer Institute

Active 2026
Enriched profilefindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLeukemiaHematology / OncologyNortheast · MA
653
publications
61
h-index
9
trials
View profile →

Nicholas Short, MD

The University of Texas MD Anderson Cancer Center

Active 2026
Enriched profileLeukemiaInternal MedicineSouth Central · TX
1,096
publications
66
h-index
15
trials
View profile →

Luciano Costa, MD, PhD

University of Alabama at Birmingham

Active 2026
Enriched profilefindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileMyelomaHematology / OncologySoutheast · AL
601
publications
61
h-index
5
trials
View profile →

Ajay Nooka, MD, MPH

Winship Cancer Institute of Emory University

Active 2026
Enriched profilefindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileMyelomaMedical OncologySoutheast · GA
691
publications
55
h-index
8
trials
View profile →

Ajai Chari, MD

University of California, San Francisco (UCSF)

Active 2025
Enriched profilefindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileMyelomaHematology / OncologyNortheast · NY
487
publications
51
h-index
7
trials
View profile →

Yvonne Efebera, MD

OhioHealth

Active 2025
Enriched profilefindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileHematologyHematologyMidwest · OH
370
publications
43
h-index
6
trials
View profile →

Andrew Yee, MD

Massachusetts General Hospital Cancer Center

Active 2026
Enriched profilefindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileMyelomaMedical OncologyNortheast · MA
314
publications
41
h-index
11
trials
View profile →

Filter, sort, and export all 28 working with Adaptive Biotechnologies in the directory